Northern Trust’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-58,048
| Closed | -$60K | – | 4356 |
|
|
2019
Q1 | $60K | Hold |
58,048
| – | – | ﹤0.01% | 4017 |
|
|
2018
Q4 | $44K | Sell |
58,048
-1,400
| -2% | -$2.11K | ﹤0.01% | 4072 |
|
|
2018
Q3 | $126K | Sell |
59,448
-19
| -0% | -$46 | ﹤0.01% | 3983 |
|
|
2018
Q2 | $137K | Buy |
59,467
+457
| +0.8% | +$1.33K | ﹤0.01% | 3951 |
|
|
2018
Q1 | $188K | Sell |
59,010
-7
| -0% | -$19 | ﹤0.01% | 3845 |
|
|
2017
Q4 | $242K | Sell |
59,017
-6,782
| -10% | -$29.5K | ﹤0.01% | 3756 |
|
|
2017
Q3 | $297K | Sell |
65,799
-10,574
| -14% | -$42.8K | ﹤0.01% | 3682 |
|
|
2017
Q2 | $255K | Sell |
76,373
-194,977
| -72% | -$809K | ﹤0.01% | 3727 |
|
|
2017
Q1 | $2.5M | Sell |
271,350
-21,144
| -7% | -$186K | ﹤0.01% | 2972 |
|
|
2016
Q4 | $2.25M | Buy |
292,494
+35,561
| +14% | +$327K | ﹤0.01% | 3020 |
|
|
2016
Q3 | $2.94M | Buy |
256,933
+33,587
| +15% | +$391K | ﹤0.01% | 2852 |
|
|
2016
Q2 | $2.75M | Buy |
223,346
+20,439
| +10% | +$248K | ﹤0.01% | 2856 |
|
|
2016
Q1 | $2.05M | Buy |
202,907
+3,033
| +2% | +$35.6K | ﹤0.01% | 2962 |
|
|
2015
Q4 | $4.5M | Buy |
199,874
+9,210
| +5% | +$189K | ﹤0.01% | 2519 |
|
|
2015
Q3 | $3.16M | Buy |
190,664
+42,219
| +28% | +$846K | ﹤0.01% | 2760 |
|
|
2015
Q2 | $3.34M | Buy |
148,445
+14,297
| +11% | +$353K | ﹤0.01% | 2783 |
|
|
2015
Q1 | $3.46M | Buy |
134,148
+5,897
| +5% | +$150K | ﹤0.01% | 2744 |
|
|
2014
Q4 | $2.79M | Sell |
128,251
-6,060
| -5% | -$124K | ﹤0.01% | 2883 |
|
|
2014
Q3 | $2.54M | Buy |
134,311
+70,200
| +109% | +$1.41M | ﹤0.01% | 2941 |
|
|
2014
Q2 | $1.49M | Buy |
64,111
+5,922
| +10% | +$146K | ﹤0.01% | 3239 |
|
|
2014
Q1 | $1.96M | Sell |
58,189
-5,787
| -9% | -$195K | ﹤0.01% | 3144 |
|
|
2013
Q4 | $1.89M | Buy |
63,976
+40,610
| +174% | +$744K | ﹤0.01% | 3186 |
|
|
2013
Q3 | $358K | Buy |
+23,366
| New | +$433K | ﹤0.01% | 3513 |
|
Northern Trust's OMED Position: Q2 2019 in Review
Northern Trust sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q2 2019, closing a stake of 58,048 shares — an estimated $60K sold.
Northern Trust first reported a position in OMED in Q3 2013 and held it in 23 quarters. The position peaked at $4.5M in Q4 2015. 0 funds tracked by Wall St. Rank hold OMED as of Q2 2019.
- Northern Trust reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
- Northern Trust sold 58,048 OncoMed Pharmaceuticals, Inc. shares in Q2 2019, an estimated $60K.
- Northern Trust first reported a position in OncoMed Pharmaceuticals, Inc. in Q3 2013 and held it in 23 quarters.
- Northern Trust's OncoMed Pharmaceuticals, Inc. position peaked at $4.5M in Q4 2015.
- 0 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2019.
Based on Northern Trust's 13F filing for Q2 2019, filed 13 Aug 2019.